相关实验视频

Updated: May 2, 2026

MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening

MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening

Published on: October 26, 2017

循环miRNA-486作为一个新的诊断生物标志物用于右心室重塑

Huiling Cai^1,2, Cheng Yu³, Xiuchuan Li²

¹Department of Cardiology, School of Clinical Medicine, Southwest Medical University, Luzhou, Sichuan, China.

Frontiers in cardiovascular medicine

|February 13, 2025

概括

血清miRNA-486显示为诊断肺高血压 (PH) 中右心室 (RV) 重塑的新生物标志物具有前途. 这一发现可能会为患有VR问题的PH患者提供改进的诊断工具.

科学领域:

心脏病学心脏病学
分子生物学分子生物学
生物标志物发现发现

背景情况:

在肺高血压 (PH) 中右心室 (RV) 重塑缺乏特定的诊断生物标志物.
微RNA (miRNA) 是VR重塑的关键调节者,但它们作为血清生物标志物的作用尚未得到充分研究.

研究的目的:

系统地选和识别候选血清miRNAs用于诊断PH患者的RV重塑.
评估人体中已识别的血清miRNAs的诊断潜力.

主要方法:

肺动脉带纹 (PAB) 的老鼠模型被用于诱导RV重塑,随后进行心声和组织学分析.
高通量血清miRNA测序确定了差异表达的miRNA (dif-miRNAs).
候选miRNA诊断功率在100名患有各种心脏病的患者中得到了验证.

主要成果:

PAB大鼠显示出显著的RV缩,纤维化和心肌细胞扩大.
密RNA测序显示了19个dif-miRNAs;PAB大鼠的血清密RNA-486显著升高.
血清miRNA-486水平区分了PH患者与对照组和LVH患者的差异,并预测了PH的RV适应不良 (AUC 0.8625).

结论:

血清miRNA-486显示出作为诊断PH的RV重塑的非侵入性生物标志物的潜力.
血清miRNA-486水平升高与VR适应不良和BNP增加的指标相关.
这一发现可能为改善PH管理中的诊断策略铺平道路.

关键词:

诊断生物标志物的生物标志物这就是miRNA-4866.肺动脉带带的形成肺高血压是一种肺高血压.右心室重建的重塑

更多相关视频

Tissue-specific miRNA Expression Profiling in Mouse Heart Sections Using In Situ Hybridization

Tissue-specific miRNA Expression Profiling in Mouse Heart Sections Using In Situ Hybridization

Published on: September 15, 2018

Digital PCR for Quantifying Circulating MicroRNAs in Acute Myocardial Infarction and Cardiovascular Disease

Digital PCR for Quantifying Circulating MicroRNAs in Acute Myocardial Infarction and Cardiovascular Disease

Published on: July 3, 2018

相关概念视频

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...

Cardiomyopathy IV: Restrictive Cardiomyopathy

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...